Pharmacokinetics of bestatin and oral activity for treatment of experimental metastases
Authors:
- 1 January 1989
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 28 (1) , 29-33
Abstract
Bestatin is a low molecular weight aminopeptidase inhibitor originally isolated from culture filtrates of Streptomyces olivoreticuli. The serum pharmacokinetics in mice are dependent on route of administration, with a short t1/2 (1.69 min t1/2α and 12.8 min t1/2β), but a high initial serum level following i.v. administration. When administered via the i.p., s.c., i.m., or p.o. routes of administration, bestatin had serum t1/2βs of 8.56, 16.91, 19.25, or 15.4 min, respectively. The maximum area under the curve (concentration×time) occurred following i.v. and i.m. administration, with a lower level following p.o. or i.p. administration. Bestatin had therapeutic activity for experimental metastases, not only following i.v., i.p., and i.m. routes of administration but also following oral administration. Because of its brief serum t1/2, bestatin's therapeutic activity depends on aggressive (either daily or twice daily injection, especially following p.o. administration) and high-dose administration. Thus, the rate-limiting aspect of bestatin's therapeutic activity appears to be associated with its pharmacokinetics.Keywords
This publication has 29 references indexed in Scilit:
- Enhancement of graft-versus-host reaction and delayed cutaneous hypersensitivity in mice by ubenimex.The Journal of Antibiotics, 1986
- Enhancement of antitumor effect of cytotoxic agents by bestatin.The Journal of Antibiotics, 1985
- Effect of Bestatin on in Vitro Responses of Murine Lymphocytes to T‐Cell StimuliScandinavian Journal of Immunology, 1984
- Increased sensitivity of IL2-dependent cultured T cells and enhancement of in vitro IL2 production by human lymphocytes treated with bestatinInternational Journal of Immunopharmacology, 1984
- Properties and specificity of binding sites for the immunomodulator bestatin on the surface of mammalian cellsInternational Journal of Immunopharmacology, 1982
- Mitogenic effect of bestatin on lymphocytes.The Journal of Antibiotics, 1980
- Effect of bestatin on mouse immune system and experimental murine tumors.The Journal of Antibiotics, 1980
- Activation of DNA metabolism in T-cells by bestatinBiochemical Pharmacology, 1979
- Stimulatory effect of Bestatin, a new specific inhibitor of aminopeptidases, on the blastogenesis of guinea pig lymphocytesCellular Immunology, 1978
- Enhancement of delayed-type hypersensitivity by bestatin, an inhibitor of aminopeptidase B and leucine aminopeptidase.The Journal of Antibiotics, 1976